Halozyme Therapeutics, Inc. (HALO) 2024年CSR报告「NASDAQ」.pdf

1、2024 Environmental,Social&Governance ReportTable of ContentsAbout Halozyme.3From Our CEO.4Our Approach to ESG.5Our People.6Diversity,Equity and Inclusion.6Recruiting Talent and Onboarding.7Employee Engagement.8Our Approach to Learning and Development.9Leadership Development Programs.10Compensation a

2、nd Benefits.11Turnover and Tenure.12Employee Health and Safety.12Our Communities.13Patients and Products(Product Quality and Safety).16Quality Management.16Reporting Adverse Events.19Clinical Trials.21Interactions with Healthcare Professionals.22Our Environment.23Leadership in Environmental Stewards

3、hip.23Moving Beyond Requirements.23Carbon and Climate.24Waste Management.25Data Privacy and Cybersecurity.26Compliance,Governance and Ethics.27Halozyme is pleased to share our corporate responsibility framework,which helps steer our business activities towards creating a beneficial impact on society

4、,both now and in the years ahead.This report chronicles our progress from January 1,2024 to December 1,2024.It encompasses insights obtained through ongoing evaluation of viewpoints from within and outside our organization,active dialogue with stakeholders,scrutiny of pertinent reporting standards a

5、nd frameworks,and an in-house review to ensure our environmental,social,and governance(ESG)priorities are in harmony with our broader strategy,mission,and core values.In preparing this report,we have adhered to the principles of the Sustainable Accounting Standards Board(SASB)and the Task Force on C

6、limate-related Financial Disclosures(TCFD)reporting guidelines.We invite you to review this report and are excited to continue developing these initiatives as we move forward.About Halozyme|From Our CEO|Our Approach|Our People|Our Communities|Patients and Products|Our Environment|Data Privacy&Cybers